论文部分内容阅读
目的:比较康莱特和高聚金葡素改善晚期癌症患者生存质量的临床疗效。方法:将78例晚期癌症患者分成2组,康莱特组40例,高聚金葡素组38例,进行临床对照观察。结果:康莱特组与高聚金葡素组比较,疼痛缓解率、生活质量评分有明显提高,统计学处理均有统计学差异(P＜0．01;P＜0．05)。两组药物均无严重毒副作用。结论:康莱特改善晚期癌症患者生存质量的临床疗效优于高聚金葡素。
OBJECTIVE: To compare the clinical effects of Kanglaite and Polyglucosamine in improving the quality of life of patients with advanced cancer. Methods: 78 patients with advanced cancer were divided into two groups: 40 cases in the KLT group and 38 cases in the group of high-grade AP-A group. Results: The pain relief rate and quality of life scores in KLT group were significantly higher than those in the high-grade APB group (P <0.01; P <0.05). Two groups of drugs without serious side effects. CONCLUSIONS: KLT is superior to hyperglucamine in improving the quality of life of advanced cancer patients.